These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8676203)
21. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211. Walicka MA; Vaidyanathan G; Zalutsky MR; Adelstein SJ; Kassis AI Radiat Res; 1998 Sep; 150(3):263-8. PubMed ID: 9728654 [TBL] [Abstract][Full Text] [Related]
22. 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation. Vaidyanathan G; Larsen RH; Zalutsky MR Cancer Res; 1996 Mar; 56(6):1204-9. PubMed ID: 8640798 [TBL] [Abstract][Full Text] [Related]
23. The nucleus is the target for radiation-induced chromosomal instability. Kaplan MI; Morgan WF Radiat Res; 1998 Oct; 150(4):382-90. PubMed ID: 9768851 [TBL] [Abstract][Full Text] [Related]
24. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
25. Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival. Walicka MA; Adelstein SJ; Kassis AI Radiat Res; 1998 Feb; 149(2):142-6. PubMed ID: 9457893 [TBL] [Abstract][Full Text] [Related]
26. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody. Lindmo T; Boven E; Mitchell JB; Morstyn G; Bunn PA Cancer Res; 1985 Oct; 45(10):5080-7. PubMed ID: 4027987 [TBL] [Abstract][Full Text] [Related]
27. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274 [TBL] [Abstract][Full Text] [Related]
28. Kinetics of micronuclei induced by 125IdU in cells of two lines. Ludwików G; Ludwików F; Johanson KJ Radiat Res; 1994 Apr; 138(1):70-8. PubMed ID: 8146302 [TBL] [Abstract][Full Text] [Related]
29. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy. Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122 [TBL] [Abstract][Full Text] [Related]
30. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer. Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069 [TBL] [Abstract][Full Text] [Related]
31. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation. Gurkan E; Schupp JE; Aziz MA; Kinsella TJ; Loparo KA Cancer Res; 2007 Nov; 67(22):10993-1000. PubMed ID: 18006845 [TBL] [Abstract][Full Text] [Related]
32. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR. Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137 [TBL] [Abstract][Full Text] [Related]
33. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats. Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385 [TBL] [Abstract][Full Text] [Related]
34. Effects of DNA-targeted ionizing radiation produced by 5-[125I]iodo-2'-deoxyuridine on global gene expression in primary human cells. Sokolov MV; Neumann RD; Panyutin IG BMC Genomics; 2007 Jun; 8():192. PubMed ID: 17594496 [TBL] [Abstract][Full Text] [Related]
35. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199 [TBL] [Abstract][Full Text] [Related]
37. A cell kinetic method for the mitotic selection of treated G2 cells. Schneiderman MH; Schneiderman GS; Rusk CM Cell Tissue Kinet; 1983 Jan; 16(1):41-9. PubMed ID: 6825155 [TBL] [Abstract][Full Text] [Related]
38. Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates. Hu Q; Hill RP Radiat Res; 1996 Dec; 146(6):636-45. PubMed ID: 8955713 [TBL] [Abstract][Full Text] [Related]
39. A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells. Dupertuis YM; Buchegger F; Pichard C Cancer Biother Radiopharm; 2003 Feb; 18(1):7-16. PubMed ID: 12667304 [TBL] [Abstract][Full Text] [Related]
40. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]